Structural, metabolic and ionic requirements for the uptake of L-carnitine by primary rat cortical cells

被引:7
作者
Virmani, MA
Rossi, S
Conti, R
Spadoni, A
ArrigoniMartelli, E
Calvani, M
机构
[1] Research and Development, Cell Pathology, Sigma-Tau, 00040 Pomezia
[2] Research and Development, Cell Pathology Department, Sigma-Tau, 0040 Pomezia, Rome
关键词
carrier-mediated; energy-dependent; Na/Cl cotransport; GABA; cortical cells;
D O I
10.1006/phrs.1996.0004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
L-Carnitine (L-C) is involved in the transport of acyl groups into mitochondria for beta-oxidation, although its role in the adult brain is still uncertain. We have shown before that the uptake of L-carnitine into cultured rat cortical neurones was dependent on temperature as well as the Na gradient and is inhibited by compounds resembling its structure, like gamma-aminobutyric acid (GABA), but most potently by specific GABA uptake blockers. In this study we have characterised this uptake process further. We have shown that the uptake of L-carnitine may be dependent on Cl ions, in addition to Na ions, but non on Ca ions. The L-C uptake was inhibited by substituent anions in the order gluconate (83%) >isethionate (32%), with propionate being ineffective, whereas GABA uptake was inhibited most potently by propionate substitution (79%) and equally by isethionate and gluconate (67%), This L-C uptake process was not affected by the amino acids, glutamine or lysine, up to 1 mM concentration, although beta-alanine at 500 mu M caused a 38% inhibition. The uptake of L-C was also significantly inhibited by structurally-related compounds, with a carbon chain length of three to six atoms, possessing an amine group and/or a carboxyl group. At a concentration of 500 mu M, 3-aminopropane sulphonic acid (53%), gamma-butyrobetaine (31%), gamma-hydroxybutyric acid (34%) and 4 methylaminobutyric acid (33%). Other compounds were effective only at the lower concentration of 10 mu M, such as butyric acid (25%), nicotinic acid (26%), isonicotinic acid (26%), hexanoic acid (23%) and at 100 mu M, like 6-aminocapric acid (22%). Drugs suggested to affect membrane properties, such as chlorpromazine, was without effect at 1 or 10 mu M, whereas flunarizine (FLU) at 1 mu M inhibited both L-C (24%) and GABA uptake (17%). Other drugs like the cholinesterase inhibitors, tacrine and eserine, also had a small inhibitory effect on L-C uptake, reducing it at 1 mu M by 22 and 21% respectively, although higher concentrations were toxic (>100 mu M). Pretreatment of the cells with neuraminidase (50 U ml(-1), 10 min) reduced the subsequent uptake of both L-C (18%) and GABA (42%). Hypoxia (3 h) also significantly attenuated L-C uptake (42%), however part of these effects were related to the loss of cell viability. In summary, L-C uptake occurs by a complex mechanism which at least in part may occur by a Na/Cl cotransport mechanism, which could be similar, to that of GABA or may even in part occur via the GABA transporter. (C) 1996 The Italian Pharmacological Society
引用
收藏
页码:19 / 27
页数:9
相关论文
共 34 条
[1]   CARNITINE TRANSPORT IN ISOLATED ADULT-RAT HEART MYOCYTES AND THE EFFECT OF 7,8-DIOH CHLORPROMAZINE [J].
BAHL, J ;
NAVIN, T ;
MANIAN, AA ;
BRESSLER, R .
CIRCULATION RESEARCH, 1981, 48 (03) :378-385
[2]   THE PHARMACOLOGY OF CARNITINE [J].
BAHL, JJ ;
BRESSLER, R .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1987, 27 :257-277
[3]  
BAHL JJ, 1980, CARNITINE BIOSYNTHES, P91
[4]   INTERACTION OF CARNITINE WITH MITOCHONDRIAL CARDIOLIPIN [J].
BATTELLI, D ;
BELLEI, M ;
ARRIGONIMARTELLI, E ;
MUSCATELLO, U ;
BOBYLEVA, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1117 (01) :33-36
[5]  
BOHMER T, 1980, CARNITINE BIOSYNTHES, P73
[6]  
BRASS EP, 1992, L CARNITINE ITS ROLE, P21
[7]   CARNITINE, CARNITINE ACYLTRANSFERASES, AND RAT-BRAIN FUNCTION [J].
BRESOLIN, N ;
FREDDO, L ;
VERGANI, L ;
ANGELINI, C .
EXPERIMENTAL NEUROLOGY, 1982, 78 (02) :285-292
[8]   NEUROLEPTIC MEDICATIONS INHIBIT COMPLEX-I OF THE ELECTRON-TRANSPORT CHAIN [J].
BURKHARDT, C ;
KELLY, JP ;
LIM, YH ;
FILLEY, CM ;
PARKER, WD .
ANNALS OF NEUROLOGY, 1993, 33 (05) :512-517
[9]   UPTAKE OF ACETYL-L-CARNITINE IN THE BRAIN [J].
BURLINA, AP ;
SERSHEN, H ;
DEBLER, EA ;
LAJTHA, A .
NEUROCHEMICAL RESEARCH, 1989, 14 (05) :489-493
[10]  
ELMESTIKAWY S, 1994, J NEUROCHEM, V62, P445